Suppr超能文献

用125碘治疗甲状腺毒症:93例患者治疗后3至5年的结果,并与131碘治疗作比较(作者译)

[Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].

作者信息

Glanzmann Ch, Horst W

出版信息

Strahlentherapie. 1979 Jan;155(1):1-5.

PMID:760268
Abstract

93 patients were treated with 125-iodine for thyrotoxicosis with a small thyroid (less than or equal to 60 gr) and without palpable nodules in the years 1972--1974. The patients were assayed by: clinical examination, radioiodine-three-phase-study and assay of hormones in the serum: thyroxine, triiodothyronine, triiodothyronine-resin-uptake and thyrotropine. The dosage was individually calculated according to the radioiodine uptake, the thyroid weight and the effective half life time of the radioiodine in the thyroid. In 60 patients the thyrotoxicosis was controlled by a single application, and in further four patients two applications eliminated the thyrotoxicosis. Two out of fifty patients with a follow up between 4 and 5 years are hypothyroid. Compared to 131-iodine therapy in a similar group, the incidence of hypothyroidism is lower after 125-iodine treatment. Only long term follow up will show, whether this advantage of 125-iodine in a very selected group of thyrotoxic patients remains. These results have encouraged us to proceed with this trial.

摘要

1972年至1974年间,93例甲状腺较小(小于或等于60克)且无可触及结节的甲状腺毒症患者接受了125碘治疗。对患者进行了以下检查:临床检查、放射性碘三相研究以及血清激素检测:甲状腺素、三碘甲状腺原氨酸、三碘甲状腺原氨酸树脂摄取率和促甲状腺素。剂量根据放射性碘摄取量、甲状腺重量以及放射性碘在甲状腺中的有效半衰期单独计算。60例患者通过单次给药控制了甲状腺毒症,另外4例患者通过两次给药消除了甲状腺毒症。在50例随访4至5年的患者中,有2例出现甲状腺功能减退。与类似组的131碘治疗相比,125碘治疗后甲状腺功能减退的发生率较低。只有长期随访才能表明,125碘在这一非常特定的甲状腺毒症患者群体中的这一优势是否依然存在。这些结果鼓励我们继续进行这项试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验